NYSE: ENFNEnfusion Inc Stock Ownership - Who owns Enfusion?
Insider buying vs selling
Have Enfusion Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Stephen Malherbe | 10% Owner | 2023-11-27 | 1,000,000 | $9.86 | $9.86MSell |
| Dan Groman | Chief Technology Officer | 2023-11-14 | 5,000 | $9.97 | $49.85kSell |
| Dan Groman | Chief Technology Officer | 2023-10-17 | 5,000 | $9.09 | $45.45kSell |
| Dan Groman | Chief Technology Officer | 2023-09-19 | 5,000 | $9.07 | $45.35kSell |
| Bronwen Bastone | Chief People Officer | 2023-09-11 | 3,182 | $8.82 | $28.07kSell |
| Dan Groman | Chief Technology Officer | 2023-08-17 | 8,065 | $8.18 | $65.97kSell |
| Bronwen Bastone | Chief People Officer | 2023-08-17 | 189 | $8.18 | $1.55kSell |
| Bronwen Bastone | Chief People Officer | 2023-08-16 | 309 | $7.94 | $2.45kSell |
| Dan Groman | Chief Technology Officer | 2023-08-16 | 13,192 | $7.94 | $104.74kSell |
| Bronwen Bastone | Chief People Officer | 2023-08-14 | 41 | $7.89 | $323.49Sell |
ENFN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ENFN insiders and whales buy or sell their stock.
ENFN Shareholders
What type of owners hold Enfusion Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Bradford E. Bernstein | 25.45% | 32,440,463 | $320.84M | Insider |
| Iconiq Capital LLC | 11.01% | 14,039,594 | $138.85M | Institution |
| Brown Capital Management LLC | 8.70% | 11,093,159 | $109.71M | Institution |
| Iconiq Strategic Partners V LP | 7.07% | 9,009,594 | $89.10M | Insider |
| Roy Luo | 7.07% | 9,009,594 | $89.10M | Insider |
| Isp Vb Ef LP | 6.08% | 7,748,000 | $76.63M | Insider |
| Hillhouse Investment Management Ltd | 3.90% | 4,975,183 | $49.20M | Insider |
| Hhlr Advisors Ltd | 3.90% | 4,975,183 | $49.20M | Institution |
| Vanguard Group Inc | 2.74% | 3,487,815 | $34.49M | Institution |
| Oleg Movchan | 2.41% | 3,076,240 | $30.42M | Insider |
ENFN vs App Stocks
Enfusion Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.